XRCC3 Thr241Met polymorphism and clinical outcomes of NSCLC patients receiving platinum-based chemotherapy: a systematic review and meta-analysis.

XRCC3 Thr241Met polymorphism and clinical outcomes of NSCLC patients receiving platinum-based chemotherapy: a systematic review and meta-analysis.

INTRODUCTION: X-ray repair cross-complementing protein 3 (XRCC3) is an essential gene involved in the double-strand break repair pathway. Published evidence has shown controversial results about the relationship between XRCC3 Thr241Met polymorphism and clinical outcomes of non-small cell lung cancer...

Full description

Bibliographic Details
Main Authors:	Xiao-yong Shen, Fan-zhen Lu, Yun Wu, Li-ting Zhao, Zhi-feng Lin
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3734199?pdf=render

Similar Items

XRCC3 Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis
by: Zhan Ping, et al.
Published: (2013-01-01)

XRCC3 Thr241Met is associated with response to platinum-based chemotherapy but not survival in advanced non-small cell lung cancer.
by: Mantang Qiu, et al.
Published: (2013-01-01)

Ethnicity-stratified analysis of the association between XRCC3 Thr241Met polymorphism and leukemia: an updated meta-analysis
by: Zhengjun Xie, et al.
Published: (2021-09-01)

To Investigate the Association of Thr241Met Polymorphisms of the XRCC3 Gene with the Risk of Breast Cancer in Women in Markazi Province
by: Ahmad Hamta, et al.
Published: (2018-03-01)

XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer.
by: Yanjing He, et al.
Published: (2018-01-01)

Associations between XRCC3 Thr241Met polymorphisms and breast cancer risk: systematic-review and meta-analysis of 55 case-control studies
by: Sepideh Dashti, et al.
Published: (2019-05-01)

Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis
by: Ningning Zhang, et al.
Published: (2020-01-01)

Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement
by: Dan-Juan Li, et al.
Published: (2017-07-01)

DNA repair gene XRCC3 241Met variant and breast cancer susceptibility of Azeri population in Iranian
by: Gohari-Lasaki Sahar, et al.
Published: (2015-01-01)

Effect of the XRCC1 and XRCC3 Genetic Polymorphisms on the Efficacy of Platinum-based Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer
by: Chong’an XU, et al.
Published: (2011-12-01)

Myocardial Infarction and AGT p.Thr174Met Polymorphism: A Meta-Analysis of 7657 Subjects
by: Yan-yan Li, et al.
Published: (2021-01-01)

Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients.
by: Ji-Ye Yin, et al.
Published: (2012-01-01)

Influence of Programmed Death Ligand-1-Gene Polymorphism rs822336 on the Prognosis and Safety of Postoperative Patients with NSCLC Who Received Platinum-Based Adjuvant Chemotherapy
by: Zhao M, et al.
Published: (2020-08-01)

Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk
by: Kaur J, et al.
Published: (2020-03-01)

Meta-Analysis of Therapy of Cinobufacini Capsule Adjunct with First-Line Platinum-Based Chemotherapy for the Treatment of Advanced NSCLC
by: Wenpan Peng, et al.
Published: (2021-01-01)

Effect of XPC polymorphisms on the response to platinum-based chemotherapy: a meta-analysis
by: Xie C, et al.
Published: (2019-05-01)

Association Studies Between XRCC1, XRCC2, XRCC3 Polymorphisms and Differentiated Thyroid Carcinoma
by: Li Yan, et al.
Published: (2016-03-01)

Predicting the Role of DNA Polymerase β Alone or with <i>KRAS</i> Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy
by: Maria Francesca Alvisi, et al.
Published: (2020-07-01)

Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies.
by: Guohua Huang, et al.
Published: (2013-01-01)

The association of <it>XRCC1 </it>gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma
by: Xie Xing, et al.
Published: (2009-06-01)

Polymorphisms of the DNA repair genes XRCC1 and XRCC3 in a Brazilian population
by: Márcia Cristina Duarte, et al.
Published: (2005-09-01)

Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
by: Claudia Bănescu, et al.
Published: (2014-01-01)

OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC
by: Yanzhang Hao, et al.
Published: (2014-01-01)

A Comprehensive Evaluation of the Association between Polymorphisms in XRCC1, ERCC2, and XRCC3 and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis
by: Yan Zhao, et al.
Published: (2019-01-01)

Polymorphism of DNA repair genes XRCC1 280, XRCC1 194, XRCC1 339 and XPD 751 with stomach cancer
by: S. S. Rakitin, et al.
Published: (2011-12-01)

Combination of EGFR-TKIs and chemotherapy as first-line therapy for advanced NSCLC: a meta-analysis.
by: Pu-Yun OuYang, et al.
Published: (2013-01-01)

Polymorphisms of ERCC1, XPD, XRCC1 and XPG Predict Clinical Outcome in Advanced Gastric Cancer Patients Receiving Oxaliplatin-Based Chemotherapy in Chinese Population
by: Jian JIANG, et al.
Published: (2009-10-01)

ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma
by: Chen L, et al.
Published: (2016-11-01)

PROGNOSTIC SIGNIFICANCE OF MET235/235THR POLYMORPHISMS OF GENE AGT FOR DEVELOPMENT OF CARDIOVASCULAR DISORDERS IN PROFESSIONAL SPORTSMEN
by: D. V. Muzhenya, et al.
Published: (2016-10-01)

Polymorphisms in DNA repair genes XRCC2 and XRCC3 risk of gastric cancer in Turkey
by: İlhami Gok, et al.
Published: (2014-09-01)

XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis.
by: Li-Wen He, et al.
Published: (2014-01-01)

DEVISING AN EXAMINATION SCHEME OF HEARING IN CHILDREN RECEIVED CHEMOTHERAPY WITH PLATINUM
by: G.S Tufatulin, et al.
Published: (2011-12-01)

DEVISING AN EXAMINATION SCHEME OF HEARING IN CHILDREN RECEIVED CHEMOTHERAPY WITH PLATINUM
by: G.S Tufatulin, et al.
Published: (2011-12-01)

Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review
by: Afifah NN, et al.
Published: (2020-10-01)

The relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in northeastern Chinese.
by: Shujie Guo, et al.
Published: (2013-01-01)

Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
by: Lei Jiang, et al.
Published: (2013-01-01)

BMP-4 Genetic Variants and Protein Expression Are Associated with Platinum-Based Chemotherapy Response and Prognosis in NSCLC
by: Sun Xian, et al.
Published: (2014-01-01)

Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy
by: Seiichiro Kusuhara, et al.
Published: (2021-05-01)

Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
by: Wen-Qi Ma, et al.
Published: (2016-01-01)

Impact of XRCC2 Arg188His polymorphism on cancer susceptibility: a meta-analysis.
by: Yazhou He, et al.
Published: (2014-01-01)